Providers - GlobalBook your demo
It's all about the stage shift
Optellum Virtual Nodule Clinic®, is a unique & complete solution for early lung cancer diagnosis with seamless EHR & PACS integration. It is UKCA and CE marked, and available for clinical use in the UK and across Europe.
Optellum is trusted by industry & academic leaders
The problem
Hospitals lose a million lung nodule patients to follow-up every year
Some of these nodules are cancer1,2
Find, Manage, Prioritize
VNC is a unique & complete solution for early lung cancer diagnosis with UKCA / CE marking. It has a triple-pronged approach
Patient Safety Net AI
Triage, track, manage
Optellum Lung Cancer Prediction® AI
Find
Patient Safety Net AI
Our Patient Safety Net AI module runs configurable and automated overnight searches to find nodules in radiology reports across hospital sites, achieving 100% sensitivity and 98% specificity,7 surfacing them more quickly than would otherwise be done.
Manage
Triage, track, manage
Our dedicated workflow management system provides incidental finding and screening dashboards with patient timelines to enable efficient enrolment and triage. Nurse navigators praise its ease of use and seamless workflow.
Prioritise
Optellum Lung Cancer Prediction® AI
Our clinically validated risk stratification & decision support tool LCP AI uses deep learning & radiomics to analyse CT images to produce a user-friendly cancer risk score, the only FDA-cleared AI solution, outperforming standard-of-care models such as Brock and Mayo.8,9
Our products
Explore our other products
LCP Maxscreen
Augmented by SYBIL (MIT License)
Our population health screening solution assesses the future risk of lung cancer up to 5 years out, empowering health systems & governments to take proactive measures
RUOPublic health
Virtual Nodule Clinic Pro
Powered by LCP AI® v2
VNC Pro, combining our core Patient Discovery AI & zcLCP technologies for the complete, automated end-to-end solution for discovering & prioritizing lung nodule patients.
RUOPublic healthPulmonologySurgery
Zero-click Lung Cancer Prediction, zcLCP®
Our fully automated, reimbursable solution augments workflows, increases throughput, and offers second-reader assurance to radiologists for lung nodules on CT images.
RUORadiologyPublic health
Discover the innovative products we're developing for our partners, coming soon
References
1. Gould et al 20152. Borg et al 20243. Dotson et al (in preparation)
4. Lee et al 20245. Conservative budget impact estimate for typical NHS 1,000-bed site based on reducing unnecessary CT and PET/CT scans. Excludes savings from avoiding benign biopsies and other late-stage disease treatments. Costs based on National Schedule of NHS Costs.6. Tsakok et al 20217. Dotson et al 20238. Wulaningsih et al 20249. Baldwin et al 202010. Detterbeck et al 2024Certification
Redefining early intervention of lung disease
starting with one of the deadliest, lung cancer
Contact usThis Optellum webpage doesn’t match your location
The information on this webpage is intended for Healthcare providers outside the US only